Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to $3.4 million.

  • BioRestorative Therapies' Total Current Liabilities fell 2501.02% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 2501.02%. This contributed to the annual value of $3.7 million for FY2024, which is 4376.33% up from last year.
  • According to the latest figures from Q3 2025, BioRestorative Therapies' Total Current Liabilities is $3.4 million, which was down 2501.02% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Total Current Liabilities registered a high of $14.7 million during Q1 2022, and its lowest value of $363822.0 during Q4 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $3.7 million (2024), whereas its average is $4.8 million.
  • In the last 5 years, BioRestorative Therapies' Total Current Liabilities crashed by 9298.62% in 2021 and then surged by 154422.03% in 2022.
  • Over the past 5 years, BioRestorative Therapies' Total Current Liabilities (Quarter) stood at $363822.0 in 2021, then surged by 1544.22% to $6.0 million in 2022, then crashed by 56.41% to $2.6 million in 2023, then soared by 43.76% to $3.7 million in 2024, then fell by 8.34% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, $3.7 million for Q2 2025, and $4.2 million during Q1 2025.